These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 6426917)
1. Definition and implications of dose-dependent kinetics in clinical medicine. Holtzman JL Drug Metab Rev; 1983; 14(6):1103-17. PubMed ID: 6426917 [No Abstract] [Full Text] [Related]
2. Dose-dependent pharmacokinetics: emphasis on phase I metabolism. Dayton PG; Sanders JE Drug Metab Rev; 1983; 14(3):347-405. PubMed ID: 6347591 [No Abstract] [Full Text] [Related]
3. Clinical pharmacokinetics of sodium valproate, carbamazepine and phenytoin. Level-dose ration and interactions. Levy RH; Moreland TA Schweiz Rundsch Med Prax; 1984 Feb; 73(6):159-63. PubMed ID: 6424205 [No Abstract] [Full Text] [Related]
4. Interindividual differences in drug oxidation: clinical importance. Sjöqvist F; von Bahr C Drug Metab Dispos; 1973; 1(1):469-82. PubMed ID: 4149420 [No Abstract] [Full Text] [Related]
5. Brain uptake of metabolites and drugs following carotid arterial injections. Oldendorf WH Trans Am Neurol Assoc; 1971; 96():46-50. PubMed ID: 4400654 [No Abstract] [Full Text] [Related]
6. Dose dependent metabolism and enterohepatic recirculation of valproic acid in the rat. Dickinson RG; Harland RC; Rodgers RM; Gordon WP; Lynn RK; Gerber N Proc West Pharmacol Soc; 1978; 21():217-20a. PubMed ID: 358207 [No Abstract] [Full Text] [Related]
7. [Alcohol and drugs]. De Baere H Tijdschr Gastroenterol; 1976; 19(2):117-23. PubMed ID: 1013984 [No Abstract] [Full Text] [Related]
8. New method that gives true least squares fit of one and two compartment open pharmacokinetic models applied to valproic acid and methadone. Lawyer CH; Gerber N Res Commun Chem Pathol Pharmacol; 1980 Nov; 30(2):253-68. PubMed ID: 6777838 [TBL] [Abstract][Full Text] [Related]
10. Application of the phenotyped panel approach to the detection of polymorphism of drug oxidation in man [proceedings]. Idle JR; Sloan TP; Smith RL; Wakile LA Br J Pharmacol; 1979 Jul; 66(3):430P-431P. PubMed ID: 526719 [No Abstract] [Full Text] [Related]
11. The role of binding kinetics in therapeutically useful drug action. Swinney DC Curr Opin Drug Discov Devel; 2009 Jan; 12(1):31-9. PubMed ID: 19152211 [TBL] [Abstract][Full Text] [Related]
12. The Upjohn Award Lecture 1981/La Conférence Upjohn 1981. The metabolism of xenobiotics in different populations. Kalow W Can J Physiol Pharmacol; 1982 Jan; 60(1):1-12. PubMed ID: 7039786 [No Abstract] [Full Text] [Related]
13. The use of single sample clearance estimates to probe hepatic drug metabolism: handprinting the influence of cigarette smoking on human hepatic drug metabolism. Bachmann KA; Nunlee M; Martin M; Schwartz J; Jauregui L; Forney RB Xenobiotica; 1990 May; 20(5):537-47. PubMed ID: 2112290 [TBL] [Abstract][Full Text] [Related]
14. [The metabolic effect of drugs on their effective strength and duration]. Remmer H Arzneimittelforschung; 1972 Feb; 22(2):292-6. PubMed ID: 5067478 [No Abstract] [Full Text] [Related]
15. Drug displacement from protein-binding and redistributional interactions. McQueen EG Prog Biochem Pharmacol; 1974; 9():122-8. PubMed ID: 4140531 [No Abstract] [Full Text] [Related]
19. Effects of anticonvulsants on learning: performance of pigeons under a repeated acquisition procedure when exposed to phenobarbital, clonazepam, valproic acid, ethosuximide and phenytoin. Picker M; Poling A J Pharmacol Exp Ther; 1984 Aug; 230(2):307-16. PubMed ID: 6431077 [TBL] [Abstract][Full Text] [Related]
20. Disposition of valproic acid in the rat: dose-dependent metabolism, distribution, enterohepatic recirculation and choleretic effect. Dickinson RG; Harland RC; Ilias AM; Rodgers RM; Kaufman SN; Lynn RK; Gerber N J Pharmacol Exp Ther; 1979 Dec; 211(3):583-95. PubMed ID: 390116 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]